HIV and Liver Disease Conference

NIH RePORTER · NIH · R13 · $30,000 · view on reporter.nih.gov ↗

Abstract

Abstract Liver disease is major contributor to morbidity/mortality among those with HIV. The etiologies of liver disease include viral hepatitis (A through E) as well as drug-induced liver toxicity. Direct and indirect effects of HIV on stellate cell activation, and on alteration of the cytokine milieu in the liver contribute to injury. Research and information sharing remain fragmented along specialty lines. In an ongoing effort to improve communication, stimulate the research agenda, and develop new productive collaborations, we propose the continuation of a series of conferences on HIV and Liver Disease. The proposed conferences will take place over a three day period in 2020, and 2022 which will bring together leading experts in the field including those in Infectious Diseases, Hepatology, Addiction Medicine, Pharmacology and Psychiatry. In addition, young investigators and trainees will be encouraged to attend via a scholarship mechanism supported by this grant. Meeting outcomes include provision of continuing medical education credit, development of a published manuscript on the subject, and possibly the creation of a web-based educational site. Particular attention will be paid to development of new research concepts and establishment of collaborative associations by participants. A new mentoring plan for trainee scholarship recipients will be introduced.

Key facts

NIH application ID
10076267
Project number
2R13AI071925-09A1
Recipient
UNIVERSITY OF CINCINNATI
Principal Investigator
KENNETH E SHERMAN
Activity code
R13
Funding institute
NIH
Fiscal year
2021
Award amount
$30,000
Award type
2
Project period
2006-07-01 → 2024-03-31